Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Transient HIV-1 Gag-protease interactions revealed by paramagnetic NMR suggest origins of compensatory drug resistance mutations.

Deshmukh L, Louis JM, Ghirlando R, Clore GM.

Proc Natl Acad Sci U S A. 2016 Nov 1;113(44):12456-12461. Epub 2016 Oct 17.

2.

Binding of Clinical Inhibitors to a Model Precursor of a Rationally Selected Multidrug Resistant HIV-1 Protease Is Significantly Weaker Than That to the Released Mature Enzyme.

Park JH, Sayer JM, Aniana A, Yu X, Weber IT, Harrison RW, Louis JM.

Biochemistry. 2016 Apr 26;55(16):2390-400. doi: 10.1021/acs.biochem.6b00012. Epub 2016 Apr 15.

3.

Unique Flap Conformation in an HIV-1 Protease with High-Level Darunavir Resistance.

Nakashima M, Ode H, Suzuki K, Fujino M, Maejima M, Kimura Y, Masaoka T, Hattori J, Matsuda M, Hachiya A, Yokomaku Y, Suzuki A, Watanabe N, Sugiura W, Iwatani Y.

Front Microbiol. 2016 Feb 3;7:61. doi: 10.3389/fmicb.2016.00061. eCollection 2016.

4.

In silico target fishing and pharmacological profiling for the isoquinoline alkaloids of Macleaya cordata (Bo Luo Hui).

Lei Q, Liu H, Peng Y, Xiao P.

Chin Med. 2015 Dec 17;10:37. doi: 10.1186/s13020-015-0067-4. eCollection 2015.

5.

Pulsed EPR characterization of HIV-1 protease conformational sampling and inhibitor-induced population shifts.

Liu Z, Casey TM, Blackburn ME, Huang X, Pham L, de Vera IM, Carter JD, Kear-Scott JL, Veloro AM, Galiano L, Fanucci GE.

Phys Chem Chem Phys. 2016 Feb 17;18(8):5819-31. doi: 10.1039/c5cp04556h.

6.

Spin labeling and Double Electron-Electron Resonance (DEER) to Deconstruct Conformational Ensembles of HIV Protease.

Casey TM, Fanucci GE.

Methods Enzymol. 2015;564:153-87. doi: 10.1016/bs.mie.2015.07.019. Epub 2015 Sep 1.

7.

Conformational variation of an extreme drug resistant mutant of HIV protease.

Shen CH, Chang YC, Agniswamy J, Harrison RW, Weber IT.

J Mol Graph Model. 2015 Nov;62:87-96. doi: 10.1016/j.jmgm.2015.09.006. Epub 2015 Sep 8.

8.

Highly resistant HIV-1 proteases and strategies for their inhibition.

Weber IT, Kneller DW, Wong-Sam A.

Future Med Chem. 2015;7(8):1023-38. doi: 10.4155/fmc.15.44. Review.

9.

Conformation of inhibitor-free HIV-1 protease derived from NMR spectroscopy in a weakly oriented solution.

Roche J, Louis JM, Bax A.

Chembiochem. 2015 Jan 19;16(2):214-8. doi: 10.1002/cbic.201402585. Epub 2014 Dec 2.

10.

A multi-drug resistant HIV-1 protease is resistant to the dimerization inhibitory activity of TLF-PafF.

Yedidi RS, Proteasa G, Martin PD, Liu Z, Vickrey JF, Kovari IA, Kovari LC.

J Mol Graph Model. 2014 Sep;53:105-11. doi: 10.1016/j.jmgm.2014.06.010. Epub 2014 Jul 4.

11.
12.

Enhanced stability of monomer fold correlates with extreme drug resistance of HIV-1 protease.

Louis JM, Tözsér J, Roche J, Matúz K, Aniana A, Sayer JM.

Biochemistry. 2013 Oct 29;52(43):7678-88. doi: 10.1021/bi400962r. Epub 2013 Oct 15.

13.

Design, synthesis and evaluation of a potent substrate analog inhibitor identified by scanning Ala/Phe mutagenesis, mimicking substrate co-evolution, against multidrug-resistant HIV-1 protease.

Yedidi RS, Muhuhi JM, Liu Z, Bencze KZ, Koupparis K, O'Connor CE, Kovari IA, Spaller MR, Kovari LC.

Biochem Biophys Res Commun. 2013 Sep 6;438(4):703-8. doi: 10.1016/j.bbrc.2013.07.117. Epub 2013 Aug 3.

14.

Crystallographic study of multi-drug resistant HIV-1 protease lopinavir complex: mechanism of drug recognition and resistance.

Liu Z, Yedidi RS, Wang Y, Dewdney TG, Reiter SJ, Brunzelle JS, Kovari IA, Kovari LC.

Biochem Biophys Res Commun. 2013 Jul 26;437(2):199-204. doi: 10.1016/j.bbrc.2013.06.027. Epub 2013 Jun 18.

15.

NMR relaxation in proteins with fast internal motions and slow conformational exchange: model-free framework and Markov state simulations.

Xia J, Deng NJ, Levy RM.

J Phys Chem B. 2013 Jun 6;117(22):6625-34. doi: 10.1021/jp400797y. Epub 2013 May 28.

16.

Conserved hydrogen bonds and water molecules in MDR HIV-1 protease substrate complexes.

Liu Z, Wang Y, Yedidi RS, Dewdney TG, Reiter SJ, Brunzelle JS, Kovari IA, Kovari LC.

Biochem Biophys Res Commun. 2013 Jan 18;430(3):1022-7. doi: 10.1016/j.bbrc.2012.12.045. Epub 2012 Dec 19.

17.

Correlating conformational shift induction with altered inhibitor potency in a multidrug resistant HIV-1 protease variant.

de Vera IM, Blackburn ME, Fanucci GE.

Biochemistry. 2012 Oct 9;51(40):7813-5. doi: 10.1021/bi301010z. Epub 2012 Sep 28.

18.

Crystal structures of multidrug-resistant HIV-1 protease in complex with two potent anti-malarial compounds.

Yedidi RS, Liu Z, Wang Y, Brunzelle JS, Kovari IA, Woster PM, Kovari LC, Gupta D.

Biochem Biophys Res Commun. 2012 May 11;421(3):413-7. doi: 10.1016/j.bbrc.2012.03.096. Epub 2012 Mar 24.

19.

HIV-1 protease with 20 mutations exhibits extreme resistance to clinical inhibitors through coordinated structural rearrangements.

Agniswamy J, Shen CH, Aniana A, Sayer JM, Louis JM, Weber IT.

Biochemistry. 2012 Apr 3;51(13):2819-28. doi: 10.1021/bi2018317. Epub 2012 Mar 20.

20.

HIV-1 Protease: Structural Perspectives on Drug Resistance.

Weber IT, Agniswamy J.

Viruses. 2009 Dec;1(3):1110-36. doi: 10.3390/v1031110. Epub 2009 Dec 3.

Supplemental Content

Support Center